Discover preclinical studies that indicate that empagliflozin reduces liver fat, improves liver function markers, and ...
News-Medical.Net on MSN4d
Study reveals the role of transcription factors as therapeutic gateways in MAFLDMetabolic dysfunction-associated fatty liver disease (MAFLD) has become a growing global health concern, affecting millions ...
Metabolic dysfunction-associated fatty liver disease (MAFLD) has become a growing global health concern, affecting millions ...
The invasive nature of lipid biopsies has lead researchers to dedicate more efforts to unveiling noninvasive diagnostic ...
Researchers from Osaka University have discovered that tricaprin enhances survival in patients with a newly identified heart ...
The liver is essential for digestion, metabolism, detoxification, and fluid regulation. While alcohol abuse is a known cause ...
Conclusion: SteatoTest is a simple and non-invasive quantitative estimate of liver steatosis and may reduce the need for liver biopsy, particularly in patients with metabolic risk factor.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback